Journal of Clinical Endocrinology & Metabolism, Vol 58, 796-803, Copyright © 1984 by Endocrine Society

ARTICLES

A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone- releasing factor

SL Asa, BW Scheithauer, JM Bilbao, E Horvath, N Ryan, K Kovacs, RV Randall, ER Laws Jr, W Singer and JA Linfoot

We report the histological, ultrastructural, and immunocytochemical features of six hypothalamic gangliocytomas associated with pituitary GH cell adenomas and/or acromegaly. In four patients, the gangliocytoma was intrasellar, and no hypothalamic investigation was performed; in two patients, autopsy confirmed hypothalamic involvement. Four patients had a gangliocytoma associated with pituitary GH cell adenoma and acromegaly; electron microscopy demonstrated an intimate association between neurons and adenomatous GH cells. One patient had a gangliocytoma and a GH cell adenoma but no clinical evidence of acromegaly. In the sixth patient, clinical and biochemical acromegaly was manifest, but no pituitary adenoma was demonstrated. Using immunocytochemistry, human pancreatic tumor GRF (hptGRF-40) was localized in the majority of neurons of all six gangliocytomas. The pituitary adenomas and nontumorous adenohypophyses were negative for hptGRF-40. In addition, somatostatin, glucagon, and GnRH were demonstrated within some neurons of several tumors; insulin and gastrin stains were equivocal. These findings confirm previous proposals of production of a GRF by such gangliocytomas. While the significance of other peptides found in some of the tumors is uncertain, the presence of hptGRF-40 in neurons of these gangliocytomas supports the theory that GRF excess is the mechanism responsible for over-production of GH and provides evidence for a syndrome of hypothalamic acromegaly.

This article has been cited by other articles:

				C. Nasr, A. Mason, M. Mayberg, S. M. Staugaitis, and S. L. Asa Acromegaly and Somatotroph Hyperplasia with Adenomatous Transformation Due to Pituitary Metastasis of a Growth Hormone-Releasing Hormone-Secreting Pulmonary Endocrine Carcinoma J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4776 - 4780. [Abstract] [Full Text] [PDF]

				E. V. Dimaraki, W. F. Chandler, M. B. Brown, C. A. Jaffe, S. Y. Kim, R. Taussig, V. Padmanabhan, and A. L. Barkan The Role of Endogenous Growth Hormone-Releasing Hormone in Acromegaly J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2185 - 2190. [Abstract] [Full Text] [PDF]

				R. D. Kineman, L. T. Teixeira, G. V. Amargo, K. T. Coschigano, J. J. Kopchick, and L. A. Frohman The Effect of GHRH on Somatotrope Hyperplasia and Tumor Formation in the Presence and Absence of GH Signaling Endocrinology, September 1, 2001; 142(9): 3764 - 3773. [Abstract] [Full Text] [PDF]

				V. Luna, F. Morales, L. M. Luengo, A. Sanz, and J. Diaz Pituitary Gangliocytoma-Adenoma Presenting With Acromegaly: Response to Treatment Arch Intern Med, April 9, 2001; 161(7): 1010 - 1011. [Full Text] [PDF]

				R. Lanzi, M. Losa, G. Mignogna, A. Caumo, and A. E. Pontiroli The Control on Growth Hormone Release by Free Fatty Acids Is Maintained in Acromegaly J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1234 - 1238. [Abstract] [Full Text]

				S. L. Asa and S. Ezzat The Cytogenesis and Pathogenesis of Pituitary Adenomas Endocr. Rev., December 1, 1998; 19(6): 798 - 827. [Abstract] [Full Text]

				M. Kovacs, R. D. Kineman, A. V. Schally, M. Zarandi, K. Groot, and L. A. Frohman Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) on GH and Insulin-Like Growth Factor I Levels in Transgenic Mice Overexpressing the Human GHRH Gene, an Animal Model of Acromegaly Endocrinology, November 1, 1997; 138(11): 4536 - 4542. [Abstract] [Full Text] [PDF]

				N. Sanno, A. Teramoto, R. Y. Osamura, S. Genka, H. Katakami, L. Jin, R. V. Lloyd, and K. Kovacs A Growth Hormone-Releasing Hormone-Producing Pancreatic Islet Cell Tumor Metastasized to the Pituitary Is Associated with Pituitary Somatotroph Hyperplasia and Acromegaly J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2731 - 2737. [Abstract] [Full Text] [PDF]

				N. Sanno, L. Jin, X. Qian, R. Y. Osamura, B. W. Scheithauer, K. Kovacs, and R. V. Lloyd Gonadotropin-Releasing Hormone and Gonadotropin-Releasing Hormone Receptor Messenger Ribonucleic Acids Expression in Nontumorous and Neoplastic Pituitaries J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1974 - 1982. [Abstract] [Full Text] [PDF]

				C. A. Jaffe, R. DeMott-Friberg, L. A. Frohman, and A. L. Barkan Suppression of Growth Hormone (GH) Hypersecretion due to Ectopic GH-Releasing Hormone (GHRH) by a Selective GHRH Antagonist J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 634 - 637. [Abstract] [Full Text] [PDF]

				J. F. Sotos Overgrowth Clinical Pediatrics, November 1, 1996; 35(11): 577 - 590. [PDF]